Johan F Vansteenkiste

Johan F Vansteenkiste

UNVERIFIED PROFILE

Are you Johan F Vansteenkiste?   Register this Author

Register author
Johan F Vansteenkiste

Johan F Vansteenkiste

Publications by authors named "Johan F Vansteenkiste"

Are you Johan F Vansteenkiste?   Register this Author

39Publications

920Reads

25Profile Views

Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data.

Acta Clin Belg 2020 Jan 14:1-8. Epub 2020 Jan 14.

Respiratory Oncology Unit, Department of Respiratory Diseases, University Hospitals KU Leuven, Catholic University Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17843286.2019.1708125DOI Listing
January 2020

Phase Ib/II Study of Capmatinib (INC280) Plus Gefitinib After Failure of Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy in Patients With EGFR-Mutated, MET Factor-Dysregulated Non-Small-Cell Lung Cancer.

J Clin Oncol 2018 11 29;36(31):3101-3109. Epub 2018 Aug 29.

Yi-Long Wu, Guangdong General Hospital and Guangdong Academy of Medical Sciences; Li Zhang, Sun Yat-sen University Cancer Center, Guangdong; Xiaoqing Liu, Affiliated Hospital of the Chinese Academy of Military Medical Sciences, Beijing; Sylvia Zhao and Bin Peng, Novartis Institutes for Biomedical Research, Shanghai, People's Republic of China; Dong-Wan Kim, Seoul National University Hospital; Dae Ho Lee, University of Ulsan College of Medicine; Myung-Ju Ahn, Samsung Medical Center, Seoul, Republic of Korea; James Chih-Hsin Yang, National Taiwan University Hospital, Taipei; Wu-Chou Su, National Cheng Kung University Hospital, Tainan, Taiwan; Johan F. Vansteenkiste, University Hospital KU Leuven, Leuven, Belgium; Enriqueta Felip, Vall d'Hebron University Hospital, Barcelona, Spain; Vincent Chia and Philippe Pultar, Novartis Pharmaceuticals, East Hanover, NJ; Sabine Glaser and Mikhail Akimov, Novartis Pharma AG, Basel, Switzerland; and Daniel S.W. Tan, National Cancer Centre Singapore, Singapore.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.77.7326DOI Listing
November 2018

Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer.

ESMO Open 2018 10;3(6):e000429. Epub 2018 Sep 10.

Respiratory Oncology Unit and Trial Unit, Department of Respiratory Diseases, University Hospitals KU Leuven, Catholic University Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2018-000429DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6190227PMC
September 2018

Immunotherapy in lung cancer.

ESMO Open 2018 9;3(1):e000311. Epub 2018 Jan 9.

Respiratory Oncology Unit (Dept Resp Medicine), University Hospitals KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/esmoopen-2017-000311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761224PMC
January 2018

Immunotherapy: Beyond Anti-PD-1 and Anti-PD-L1 Therapies.

Am Soc Clin Oncol Educ Book 2016 ;35:e450-8

From the Department of Thoracic Oncology Moffitt Cancer Center, Tampa, FL; Respiratory Oncology Unit, University Hospital KU Leuven, Leuven, Belgium; Hospital of the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/EDBK_158712DOI Listing
January 2017

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.

J Thorac Oncol 2015 Dec;10(12):1675-84

*Division of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan; †Cancer Research and Biostatistics, Seattle, Washington; ‡Academic Department of Thoracic Surgery, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, London, United Kingdom; §Thoracic Service, Memorial Sloan-Kettering Cancer Center, New York, New York; ‖Respiratory Oncology Unit (Pulmonology), University Hospital KU Leuven, Leuven, Belgium; ¶Department of Radiology, National Cancer Center Hospital, Tokyo, Japan; #Department of Thoracic Surgery, Guangdong Provincial People's Hospital, Guangzhou, People's Republic of China; **Department of Thoracic Surgery, Pulmonary Hospital, Zakopane, Poland; ††Department of Radiotherapy, Peter MacCallum Cancer Centre, Melbourne, Australia; ‡‡Department of Thoracic Surgery, Hospital Universitari Mútua Terrassa, University of Barcelona, §§CIBERES Lung Cancer Group, Terrassa, Barcelona, Spain; and ‖‖Members of the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee, Advisory Board Members, and Participating Institutions are listed in Appendix.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000678DOI Listing
December 2015

Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung Cancer.

J Thorac Oncol 2015 Oct;10(10):1458-67

*Thoracic Oncology Unit, Arnaud de Villeneuve Hospital/CHRU Montpellier, Montpellier, France; †Department of Pneumology, University Hospital, KU Leuven, Leuven, Belgium; ‡Medical Oncology, European Institute of Oncology, Milan, Italy; §Division of Hematology and Hematologic Malignancies, University of Utah Huntsman Cancer Institute, Salt Lake City, Utah; ¶Department of Thoracic Oncology, Hospital Grosshansdorf, Grosshansdorf, Germany; ‖Department of Respiratory Medicine, Ziekenhuis Oost Limburg, Genk and LCRP Oncology Cluster, University of Hasselt, Hasselt, Belgium; #Department of Medical Oncologie, ICO R. Gauducheau, St-Herblain, France; **Department of Oncology, University Hospital S. Maria della misericordia, Udine, Italy; ††Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom; ‡‡Northwest Lung Centre, University Hospitals of South Manchester, Manchester, United Kingdom; §§Thoracic Oncology-Pneumology Service, André Renard Clinic, Herstal, Belgium; ¶¶Clinic of Thoracic Surgery, Waldburg-Zeil Clinic, Wangen im Allgäu, Germany; and ‖‖GSK Vaccines, Rixensart, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000653DOI Listing
October 2015

Ceritinib for treatment of ALK-rearranged advanced non-small-cell lung cancer.

Future Oncol 2014 Oct 23;10(12):1925-39. Epub 2014 May 23.

University Hospital KU Leuven, Respiratory Oncology Unit (Pulmonology), Herestraat 49, Leuven B-3000, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.94DOI Listing
October 2014

A rare central thoracic tumor.

J Thorac Oncol 2014 Jun;9(6):897-9

*Department of Pulmonology, †Department of Thoracic Surgery, ‡Department of Cardiac Surgery, §Department of Pathology, University Hospital KU Leuven, Leuven, Belgium; and ‖Department of Human Genetics, KU Leuven and University Hospital KU Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000162DOI Listing
June 2014

Safety and efficacy of darbepoetin alpha in previously untreated extensive-stage small-cell lung cancer treated with platinum plus etoposide.

J Clin Oncol 2008 May;26(14):2342-9

Division of Oncology, Department of Internal Medicine I, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.15.0748DOI Listing
May 2008

Endobronchial ultrasonography in bronchoscopic occult pulmonary lesions.

J Thorac Oncol 2007 Feb;2(2):121-4

Department of Pulmonology (Respiratory Oncology Unit) and Leuven Lung Cancer Group, Catholic University, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/jto.0b013e31802fbc96DOI Listing
February 2007

Every 3 weeks dosing with darbepoetin alfa: A new paradigm in anaemia management.

Cancer Treat Rev 2006 ;32 Suppl 2:S11-5

UZ Gasthuisberg, Catholic University of Leuven, Herestraat 49, 3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2006.04.006DOI Listing
August 2006

The effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer.

Expert Rev Anticancer Ther 2006 Apr;6(4):531-44

University Hospital Gasthuisberg, Respiratory Oncology Unit, Dept of Pulmonology, Herestraat 49, B-3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.1586/14737140.6.4.531
Publisher Site
http://dx.doi.org/10.1586/14737140.6.4.531DOI Listing
April 2006

PET scan in lung cancer: current recommendations and innovation.

J Thorac Oncol 2006 Jan;1(1):71-3

Department of Pulmonology, Respiratory Oncology Unit and PET Center (Nuclear Medicine), Leuven Lung Cancer Group, Leuven, Belgium.

View Article

Download full-text PDF

Source
January 2006

The future of adjuvant chemotherapy for resected non-small cell lung cancer.

Expert Rev Anticancer Ther 2005 Feb;5(1):165-75

Respiratory Oncology Unit (Pulmonology), Leuven Lung Cancer Group, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.5.1.165DOI Listing
February 2005

Seeking a home for a PET, part 3: Emerging applications of positron emission tomography imaging in the management of patients with lung cancer.

Chest 2004 Nov;126(5):1656-66

Division of Cardiothoracic Surgery, Medical School Wing C - Room 354, CB #7065, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7065, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S001236921531384
Publisher Site
http://dx.doi.org/10.1378/chest.126.5.1656DOI Listing
November 2004

Nodules, CT-scans and PET-scans: a good partnership.

Lung Cancer 2004 Jul;45(1):29-30

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2004.02.012DOI Listing
July 2004

Positron emission tomography in the management of non-small cell lung cancer.

Hematol Oncol Clin North Am 2004 Feb;18(1):269-88

Respiratory Oncology Unit, Department of Pulmonology, Leuven Lung Cancer Group, University Hospital Gasthuisberg, Catholic University, Herestraat 49, B-3000 Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0889-8588(03)00152-7DOI Listing
February 2004

PET scan in the staging of non-small cell lung cancer.

Lung Cancer 2003 Dec;42 Suppl 1:S27-37

Respiratory Oncology Unit, Pulmonology, and Leuven Lung Cancer Group, Catholic University Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-5002(03)00302-7DOI Listing
December 2003

Measurement of perfusion in stage IIIA-N2 non-small cell lung cancer using H(2)(15)O and positron emission tomography.

Clin Cancer Res 2002 Jul;8(7):2109-15

Clinical PET Centre and Departments of Pulmonary Medicine, VU University Medical Centre, 1007 MB Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
July 2002

FDG-PET in the Locoregional Lymph Node Staging of Non-small Cell Lung Cancer. A Comprehensive Review of the Leuven Lung Cancer Group Experience.

Clin Positron Imaging 1999 Jul;2(4):223-231

Respiratory Oncology Unit, Department of Pulmonology, University Hospital Gasthuisberg, Catholic University, Leuven, Belgium

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1095-0397(99)00026-6DOI Listing
July 1999